AbbVie Lowers 2025 Earnings Forecast After USD 20 Billion Acquisition Spree Farhat Nasim5 April 2025 11:15 AM ISTAbbVie has been focusing on expanding its pipeline since its blockbuster arthritis drug, Humira, lost patent protection in 2023.
U S government sets penalties on 43 drugs over price hikes Ruchika Sharma11 Jun 2023 2:30 PM ISTThe Medicare agency plans to send the first invoices to drugmakers in 2025 for the rebates owed to Medicare this year and for 2024.
AbbVie trims profit forecasts on IPRnD expenses Ruchika Sharma7 April 2023 2:30 PM ISTUnited States: AbbVie Inc has lowered its full-year and first-quarter profit expectations, citing a $150 million hit from acquired in-process...
Cigna expects revenue gains from launches of Humira biosimilars Ruchika Sharma7 Feb 2023 11:44 AM ISTCigna's PBM unit has both Humira and Amgen's Amjevita on its list of covered drugs.
Sandoz, Teva Pharma plans to ramp up biosimilars production Ruchika Sharma23 Nov 2022 1:30 PM ISTTeva Chief Executive KÃ¥re Schultz said the company was targeting "80% of what's going off-patent in the next 10 years" including big sellers like the...
USFDA adds strict safety warnings on Pfizer, AbbVie, Lilly arthritis drugs Ruchika Sharma4 Dec 2021 3:12 PM ISTNew Delhi: The U.S. health regulator has added its strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of...
Roche, Sanofi arthritis drugs Actemra, Kevzara respectively reduce death rates among sickest COVID patients: Study Ruchika Sharma9 Jan 2021 9:00 AM ISTLondon: Treating critically ill COVID-19 patients with Roche's Actemra or Sanofi's Kevzara arthritis drugs significantly improves survival rates and...
Eli Lilly arthritis drug baricitinib in combination with remdesivir gets USFDA okay to treat Covid Ruchika Sharma22 Nov 2020 11:00 AM ISTNew Delhi: The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co's arthritis drug, baricitinib, in...
Setback: Novartis arthritis drug Canakinumab fails to help Covid patients Ruchika Sharma8 Nov 2020 11:00 AM ISTZurich: Novartis's canakinumab failed to help Covid-19 patients survive without invasive ventilation compared with standard therapy, the Swiss...
Arthritis drug Baricitinib potential treatment candidate for COVID-19 Dr. Kamal Kant Kohli10 Jun 2020 8:23 PM ISTBaricitinib may be new treatment for COVID-19 finds a new study.Baricitinib is a once-daily oral drug used for treatment of adult patients with...
Arthritis Drug Tocilizumab may show promise in COVID-19 Pneumonia Hina Zahid1 May 2020 5:45 PM ISTIn an effort to put brakes on ever growing pandemic of Covid 19, researchers are leaving no stone unturned. Next in the list is rheumatoid arthritis...
Medicine for arthritis effective for treating chikungunya: Doc savita thakur thakur29 Nov 2016 11:05 AM ISTKochi:Â Medicines for arthritis is very effective for treatment of chikungunya disease which is found to be rearing its head in various parts of India,...
